Biotech

All Articles

Metsera partner with Amneal to latch down GLP-1 source

.Along with very early phase 1 data now out in the wild, metabolic health condition ensemble Metsera...

Rivus blog posts information to support muscle-sparing being overweight medicine cases

.Rivus Pharmaceuticals has introduced the records responsible for its phase 2 excessive weight gain ...

BMS spends $110M to create T-cell therapy deal, helping Main purchase time to advance prioritized pipeline

.Bristol Myers Squibb is paying for Excellent Medication $110 million ahead of time to create reagen...

Generate increases yet another $1B-plus Large Pharma partnership

.Novartis has actually printer inked a package potentially worth greater than $1 billion with Flagsh...

Metsera GLP-1 information slice shows 7.5% weight-loss at 36 times

.Lately debuted Metsera is unfolding some period 1 data for its own GLP-1 receptor agonist, uncoveri...

Flagship wishes biotechs flock to Mirai to boost genetic medications

.Amidst the genetic medications arms race, Main Pioneering is unveiling a brand-new business to aid ...

BioAge eyes $180M coming from IPO, private positioning for weight problems trials

.BioAge Labs is actually looking at about $180 thousand in preliminary earnings coming from an IPO a...

Merck's LAG-3 combo fails intestines cancer cells phase 3 research

.An effort through Merck &amp Co. to unlock the microsatellite steady (MSS) metastatic colorectal ca...

Spanish VC finalizes $200M lifestyle sciences fund

.Spain-based Asabys Partners has actually closed a fund of 180 million europeans ($ 200 million), ca...

BioAge produces $198M from IPO as obesity biotech joins Nasdaq

.BioAge Labs is actually generating nearly $200 million using its own Nasdaq IPO this morning, with ...